Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | PPARG | P37231 | 4/20 | 0.37 |
| ▸ | PPARA | Q07869 | 3/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.37 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.36 |
| ▸ | FABP7 | O15540 | 2/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.36 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31369857 | 0.89 | LPAR1 (0.46) | KMT2AFABP5LPAR1MDM2 | |
| SCHEMBL31688634 | 0.87 | KMT2A (0.37) | KMT2AOPRD1FABP5FABP7LPAR1 | |
| SCHEMBL31369593 | 0.85 | FABP5 (0.42) | KMT2APPARGPPARAOPRD1FABP5 | |
| SCHEMBL31370020 | 0.83 | KMT2A (0.42) | KMT2AOPRD1FABP5FABP7CASP3 | |
| SCHEMBL31369526 | 0.83 | KMT2A (0.42) | KMT2AFABP5FABP7MDM2CASP3 | |
| SCHEMBL30639568 | 0.82 | KMT2A (0.44) | KMT2AOPRD1FABP5FABP7CASP3 | |
| SCHEMBL21952273 | 0.82 | KMT2A (0.44) | KMT2AOPRD1FABP5FABP7CASP3 | |
| Hydrochloric Acid SCHEMBL31688770 | 0.82 | KMT2A (0.41) | KMT2AOPRD1FABP5FABP7CASP3 | |
| SCHEMBL31688945 | 0.82 | KMT2A (0.36) | KMT2AOPRD1FABP5FABP7MDM2 | |
| SCHEMBL31688637 | 0.82 | KMT2A (0.36) | KMT2AOPRD1FABP5FABP7MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | claimed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | KMT2A 3415/4885PPARG 3591/4885PPARA 3450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.